Berkeley, Inc Amgen Inc Transaction History

Berkeley, Inc

  • $193 Billion
  • Q4 2024

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Mar 28, 2025
SELL
$255.7 - $288.46 $10,739 - $12,115
-42 Reduced 0.51%
8,138 $2.34 Billion
Q4 2023

Mar 04, 2025
SELL
$255.7 - $288.46 $10,739 - $12,115
-42 Reduced 0.51%
8,138 $2.34 Billion
Q3 2023

Mar 28, 2025
BUY
$218.65 - $271.46 $5,684 - $7,057
26 Added 0.32%
8,180 $2.2 Billion
Q3 2023

Mar 04, 2025
BUY
$218.65 - $271.46 $5,684 - $7,057
26 Added 0.32%
8,180 $2.2 Billion
Q2 2023

Mar 28, 2025
BUY
$214.27 - $253.37 $283,264 - $334,955
1,322 Added 19.35%
8,154 $1.81 Billion
Q2 2023

Mar 04, 2025
BUY
$214.27 - $253.37 $283,264 - $334,955
1,322 Added 19.35%
8,154 $1.81 Billion
Q1 2023

Mar 28, 2025
BUY
$225.79 - $275.2 $102,960 - $125,491
456 Added 7.15%
6,832 $1.65 Billion
Q1 2023

Mar 04, 2025
BUY
$225.79 - $275.2 $102,960 - $125,491
456 Added 7.15%
6,832 $1.65 Billion
Q4 2022

Mar 28, 2025
BUY
$229.03 - $291.01 $1.46 Million - $1.86 Million
6,376 New
6,376 $1.67 Billion
Q4 2022

Mar 04, 2025
SELL
$229.03 - $291.01 $1.27 Million - $1.62 Million
-5,565 Reduced 46.6%
6,376 $1.67 Billion
Q3 2022

Mar 28, 2025
BUY
$224.46 - $253.15 $15,487 - $17,467
69 Added 0.58%
11,941 $2.69 Billion
Q3 2022

Mar 04, 2025
BUY
$224.46 - $253.15 $15,487 - $17,467
69 Added 0.58%
11,941 $2.69 Billion
Q2 2022

Mar 28, 2025
BUY
$230.71 - $256.74 $2,999 - $3,337
13 Added 0.11%
11,872 $2.89 Billion
Q2 2022

Mar 04, 2025
BUY
$230.71 - $256.74 $2,999 - $3,337
13 Added 0.11%
11,872 $2.89 Billion
Q1 2022

Mar 28, 2025
BUY
$219.27 - $242.57 $90,997 - $100,666
415 Added 3.63%
11,859 $2.87 Billion
Q1 2022

Mar 04, 2025
BUY
$219.27 - $242.57 $90,997 - $100,666
415 Added 3.63%
11,859 $2.87 Billion
Q4 2021

Mar 28, 2025
SELL
$198.88 - $227.6 $512,116 - $586,070
-2,575 Reduced 18.37%
11,444 $2.57 Billion
Q4 2021

Mar 04, 2025
SELL
$198.88 - $227.6 $512,116 - $586,070
-2,575 Reduced 18.37%
11,444 $2.57 Billion
Q3 2021

Mar 28, 2025
BUY
$212.27 - $248.7 $57,100 - $66,900
269 Added 1.96%
14,019 $2.98 Billion
Q3 2021

Mar 04, 2025
BUY
$212.27 - $248.7 $57,100 - $66,900
269 Added 1.96%
14,019 $2.98 Billion
Q2 2021

Mar 28, 2025
BUY
$233.58 - $259.14 $147,388 - $163,517
631 Added 4.81%
13,750 $3.35 Billion
Q2 2021

Mar 04, 2025
BUY
$233.58 - $259.14 $147,388 - $163,517
631 Added 4.81%
13,750 $3.35 Billion
Q1 2021

Mar 28, 2025
BUY
$221.91 - $258.6 $2.91 Million - $3.39 Million
13,119 New
13,119 $3.26 Billion
Q1 2021

Mar 04, 2025
BUY
$221.91 - $258.6 $421,850 - $491,598
1,901 Added 16.95%
13,119 $3.26 Billion
Q4 2020

Mar 28, 2025
BUY
$216.38 - $257.67 $2.43 Million - $2.89 Million
11,218 New
11,218 $2.58 Billion
Q4 2020

Feb 28, 2025
BUY
$216.38 - $257.67 $2.43 Million - $2.89 Million
11,218 New
11,218 $2.58 Billion

Others Institutions Holding AMGN

# of Institutions
3,203
Shares Held
422M
Call Options Held
7.05M
Put Options Held
6.39M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $167B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Berkeley, Inc Portfolio

Follow Berkeley, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkeley, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Berkeley, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email